Ming Yang

Biography and Expertise of Ming Yang

Dr. Ming Yang is a physician and researcher dedicated to advancing evidence-based integrative oncology. He works at the Third Affiliated Hospital of the Beijing University of Chinese Medicine, where his practice and research center on the use of acupuncture and moxibustion for cancer care. His primary clinical interest involves leading innovative trials to address treatment-related complications, such as low anterior resection syndrome (LARS) in colorectal cancer survivors. This condition significantly impacts quality of life, and Dr. Yang’s work explores non-pharmacological solutions.

His expertise directly supports the congress thematic axis, “Contributions of TCIM to Global Public Health (Evidence-Based).” By designing and executing rigorous clinical trials on electroacupuncture, Ming Yang generates crucial data demonstrating improvements in bowel function and quality of life for patients. Furthermore, his work exemplifies the “Integration of TCIM into Health Systems” axis, as he applies traditional Chinese medicine techniques within a modern hospital oncology department to solve pressing clinical problems. His role as a Principal Investigator for funded studies underscores his contribution to building a credible scientific foundation for acupuncture in supportive cancer care.

Professional Career of Ming Yang

The professional career of Ming Yang is centered at the intersection of clinical practice and academic research within one of China’s foremost institutions for traditional medicine. As an Attending Physician at the Third Affiliated Hospital of Beijing University of Chinese Medicine, he is responsible for patient care in the Department of Acupuncture and Minimally Invasive Oncology. This role involves applying traditional techniques to support patients undergoing conventional cancer treatments, aiming to manage side effects and improve their overall well-being.

In addition to his clinical duties, Dr. Yang is an active researcher, holding key responsibilities in scientific investigation. His career reflects a commitment to validating traditional therapies through modern research methodologies. This dual focus ensures that his clinical work is informed by the latest evidence while his research remains grounded in real-world patient needs.

• Attending Physician: Serves in the Department of Acupuncture and Minimally Invasive Oncology, providing specialized care that integrates traditional Chinese medicine with modern oncological practices.
• Principal Investigator (PI): Leads a research project funded by the Capital’s Funds for Health Research. In this capacity, he oversees all aspects of a clinical trial investigating acupuncture’s efficacy for rectal cancer patients with low anterior resection syndrome.
• Co-author and Researcher: Contributed as a co-author to a Cochrane Systematic Review. This role involved the critical appraisal and synthesis of evidence on the use of Chinese herbs for managing chemotherapy side effects in breast cancer patients, contributing to a high-level evidence summary.

Academic Qualifications

Dr. Ming Yang built his entire academic foundation at the Beijing University of Chinese Medicine (BUCM), a globally recognized institution for traditional Chinese medicine. His educational path shows a clear and focused progression, starting with fundamental principles and culminating in advanced research methodologies for integrative, evidence-based medicine. This comprehensive training provides a deep understanding of both traditional knowledge and contemporary scientific standards.

This academic trajectory equipped him with the skills to design and conduct high-quality clinical trials bridging traditional practices and modern healthcare. Therefore, his qualifications are central to his work generating reliable evidence for integrative oncology.

• Ph.D., Integrative Evidence-based Medicine: This doctorate represents the highest training in the scientific evaluation of integrative medicine. The program focuses on clinical trial design, biostatistics, systematic reviews, and the critical appraisal of evidence, enabling Dr. Yang to lead rigorous research projects.
• M.S., Clinical Science of Integrative Medicine: His master’s degree provided specialized clinical research training within an integrative context. This stage of his education focused on applying scientific methods to study the effectiveness and safety of combining traditional and conventional therapies at The Third Affiliated Hospital, BUCM.
• B.S., Traditional Chinese Medicine: Dr. Yang’s undergraduate education provided him with a comprehensive grounding in the theories, diagnostics, and therapeutic modalities of traditional Chinese medicine, including acupuncture, moxibustion, and herbal medicine. This foundational knowledge is essential for his clinical practice and research.

Research and Publications of Ming Yang

Dr. Ming Yang‘s research focuses on creating a scientific evidence base for Traditional Chinese Medicine (TCM) in supportive cancer care. His work utilizes high-quality clinical trial methodology and mixed-methods research. He has authored numerous first-author publications in high-impact international journals, sharing his findings with a global audience.

As a Principal Investigator and contributor to systematic reviews, Ming Yang‘s research helps inform clinical guidelines and promotes the integration of safe, effective traditional therapies into conventional oncology. He is also an active presenter at global integrative oncology conferences, contributing to international scientific discourse.

Key Research Areas

• Evidence-based Integrative Oncology: The core of his work, focusing on integrating TCM therapies into cancer treatment plans using evidence-based medicine.
• Acupuncture & Moxibustion for Cancer Care: Investigates the mechanisms and clinical effects of acupuncture and moxibustion for managing symptoms like pain, nausea, and functional disorders from cancer treatments.
• Chinese Herbal Medicine in Oncology Support: Researches the role of herbal formulas in mitigating side effects of chemotherapy and radiation.

Selected Research Projects

• Acupuncture for LARS: As Principal Investigator, he leads a funded trial on acupuncture for rectal cancer patients with low anterior resection syndrome (LARS). Pilot studies show significant improvements.
• Cochrane Systematic Review: Co-authored a review of evidence on Chinese herbs for chemotherapy side effects in breast cancer, synthesizing knowledge for clinicians.

Connect with Dr. Yang

For a detailed record of Dr. Ming Yang‘s publications, research projects, and professional contributions, his Open Researcher and Contributor ID (ORCID) profile provides a comprehensive and authoritative source of information. This platform is widely used in the academic community to ensure proper attribution of scholarly work.

ORCID Profile: https://orcid.org/0000-0002-2954-7435